Lee, G., Rosa, B., Fernandez-Baca, M., Martin, J., Ore, R., Ortiz-Oblitas, P., . . . Mitreva, M. (2025). Distinct gut microbiome features characterize Fasciola hepatica infection and predict triclabendazole treatment outcomes in Peruvian patients.
Citación estilo ChicagoLee, G., B.A Rosa, M.V Fernandez-Baca, J. Martin, R.A Ore, P. Ortiz-Oblitas, M.M Cabada, y M. Mitreva. Distinct Gut Microbiome Features Characterize Fasciola Hepatica Infection and Predict Triclabendazole Treatment Outcomes in Peruvian Patients. 2025.
Cita MLALee, G., et al. Distinct Gut Microbiome Features Characterize Fasciola Hepatica Infection and Predict Triclabendazole Treatment Outcomes in Peruvian Patients. 2025.